Philadelphia, PA - BioLabs is thrilled to announce the expansion and renaming of its Philadelphia location to BioLabs for Advanced Therapeutics. Currently under construction at the Curtis, the 30,000-square-foot incubator is set for completion by Q3 of 2025. The enhanced site will feature nine conference rooms, premium event space for life science gatherings, and a variety of specialized support labs focusing on microbiology, microscopy, process development, and more. While continuing its commitment to high-potential life science startups of all types, the newly upgraded facility will go beyond traditional coworking lab spaces by also offering an advanced suite of specialized equipment and tailored educational events designed to accelerate innovation in the advanced therapeutics sector.
A Hub for Advanced Therapeutics Collaboration
A unique highlight of Biolabs for Advanced Therapeutics will be the inclusion of Thermo Fisher Scientific’s east-coast flagship Advanced Therapies Collaboration Center (ATxCC). This embedded resource is expected to draw companies from across the eastern seaboard, providing direct access to the BioLabs community, Thermo Fisher’s expert scientists, and cutting-edge equipment for advanced therapeutics R&D and process development. A dedicated announcement detailing this collaboration will be released soon. In the meantime, please visit thermofisher.com/celltherapycollaborations to learn more about Thermo Fisher’s collaboration program.
Key Benefits for Startups
Integrated Biotech Ecosystem – BioLabs for Advanced Therapeutics offers startups an unparalleled opportunity to connect with venture capital, industry experts, and collaborators through the global BioLabs network and the broader East Coast advanced therapeutics community.
Accelerated Path to Patients – The site will provide a specialized suite of process development equipment, enabling startups to develop advanced therapeutics faster, more cost-effectively, and with fewer critical mistakes.
Direct Collaboration with Thermo Fisher Scientific – Startups will have the opportunity to work directly with onsite Thermo Fisher scientists at the Advanced Therapies Collaboration Center, gaining valuable expertise in cell therapy, gene therapy, and related technologies.
Scalability and Growth – Located in the heart of Philadelphia, the Curtis offers easy access to a cold-chain-enabled airport, public transit, and key biotech resources, ensuring seamless logistics and connectivity. Companies can scale organically from R&D to clinical-trial-ready, all in one state-of-the-art facility — and then step into cGMP space within the same building.
A Legacy of Innovation and Impact
Since its inception in 2009, BioLabs has been dedicated to fostering biotech innovation by creating optimal environments for innovators. Through fully equipped coworking lab and office spaces, robust educational programs, and strategic industry connections, BioLabs has become a launchpad for over 550 life science startups across 16 locations in the US, Europe and Japan.
In Philadelphia alone, BioLabs member companies have raised over $2 billion in funding since 2018, and 7 alumni companies have progressed to clinical trials.
Secure Your Space at BioLabs for Advanced Therapeutics
Leasing begins this spring! Early members will receive priority space reservations and first-mover pricing. Lab spaces ranging from a single bench in our shared open lab to private 23-bench graduate suites will be available by Q3 of 2025, with a limited number of spaces available immediately.
Don’t miss this opportunity to be part of a groundbreaking biotech community. Join BioLabs for Advanced Therapeutics and accelerate your journey from discovery to clinical success!
For more details or to schedule a hard-hat tour, reach out to Melina Blees, PhD, Site Head of BioLabs for Advanced Therapeutics, by completing the contact form at biolabs.io/philly
High-potential startups are encouraged to apply at connect.biolabs.io/apply
